Referred to the House Committee on Energy and Commerce.
This bill bars the Department of Health and Human Services from conducting or funding biomedical research that tests on vertebrate animals in facilities located in, or owned or controlled by, specified foreign countries (China including Hong Kong, Iran, North Korea, Russia) or any other country designated by HHS in consultation with State and Defense. It also prohibits HHS support (grants, contracts, cooperative agreements, etc.) for animal-testing research conducted by entities based in those countries.
Liberals worry about research and public-health collaboration impacts
Relative to its intended legislative type, this bill clearly states a substantive prohibition on HHS-supported vertebrate animal research in specified foreign countries and prescribes a process for adding countries with an accountability report.
This bill bars the Department of Health and Human Services from conducting or funding biomedical research that tests on vertebrate animals in facilities located in, or owned or controlled by, specified foreign countries (China including Hong Kong, Iran, North Korea, Russia) or any other country designated by HHS in consultation with State and Defense.
It also prohibits HHS support (grants, contracts, cooperative agreements, etc.) for animal-testing research conducted by entities based in those countries.
When HHS designates an additional country of concern, the Secretary must report the detailed rationale to specified congressional committees within 60 days.
Narrow, security-oriented ban increases chances, but limited legislative priority, potential scientific community resistance, and Senate procedure reduce overall probability.
Relative to its intended legislative type, this bill clearly states a substantive prohibition on HHS-supported vertebrate animal research in specified foreign countries and prescribes a process for adding countries with an accountability report. However, it provides limited operational detail, lacks definitions of key terms, does not integrate with existing statutory grant frameworks, and omits fiscal and enforcement provisions.
Liberals worry about research and public-health collaboration impacts
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals worry about research and public-health collaboration impacts
Likely cautiously supportive of restricting taxpayer funding tied to authoritarian adversaries, but concerned about research collaboration and public health implications.
May worry the designation process is opaque and could limit vital international disease research or animal welfare oversight improvements.
Wants clear exceptions and transparency to prevent unintended harm to global health efforts.
Generally supportive as a targeted national-security and oversight measure, but wary of operational and diplomatic side effects.
Will press for clarity on definitions, implementation, and emergency exceptions to avoid interrupting critical research.
Seeks procedures minimizing compliance burdens and preserving legitimate public-health collaborations.
Likely broadly supportive as a measure that prevents U.S. taxpayer dollars from aiding geopolitical adversaries.
Views the bill as a prudent national-security and economic-protection step, while favoring strong enforcement.
May prefer extending similar restrictions across agencies.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Narrow, security-oriented ban increases chances, but limited legislative priority, potential scientific community resistance, and Senate procedure reduce overall probability.
The bill has not accumulated any surfaced votes yet.
Liberals worry about research and public-health collaboration impacts
Narrow, security-oriented ban increases chances, but limited legislative priority, potential scientific community resistance, and Senate pr…
Relative to its intended legislative type, this bill clearly states a substantive prohibition on HHS-supported vertebrate animal research in specified foreign countries and prescribes a process for adding countries with…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.